Avanos Medical (AVNS) Competitors $10.86 +0.16 (+1.50%) Closing price 03:59 PM EasternExtended Trading$10.84 -0.02 (-0.18%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AVNS vs. PRCT, LMAT, AORT, LQDA, ENOV, NVCR, CDRE, CNMD, SSII, and PLSEShould you be buying Avanos Medical stock or one of its competitors? The main competitors of Avanos Medical include PROCEPT BioRobotics (PRCT), LeMaitre Vascular (LMAT), Artivion (AORT), Liquidia Technologies (LQDA), Enovis (ENOV), NovoCure (NVCR), Cadre (CDRE), CONMED (CNMD), SS Innovations International (SSII), and Pulse Biosciences (PLSE). These companies are all part of the "medical equipment" industry. Avanos Medical vs. Its Competitors PROCEPT BioRobotics LeMaitre Vascular Artivion Liquidia Technologies Enovis NovoCure Cadre CONMED SS Innovations International Pulse Biosciences PROCEPT BioRobotics (NASDAQ:PRCT) and Avanos Medical (NYSE:AVNS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends. Which has stronger earnings & valuation, PRCT or AVNS? PROCEPT BioRobotics has higher earnings, but lower revenue than Avanos Medical. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPROCEPT BioRobotics$224.50M8.18-$91.41M-$1.55-21.29Avanos Medical$692.50M0.73-$392.10M-$10.07-1.08 Is PRCT or AVNS more profitable? PROCEPT BioRobotics has a net margin of -30.60% compared to Avanos Medical's net margin of -66.89%. Avanos Medical's return on equity of 6.16% beat PROCEPT BioRobotics' return on equity.Company Net Margins Return on Equity Return on Assets PROCEPT BioRobotics-30.60% -23.73% -17.34% Avanos Medical -66.89%6.16%4.57% Which has more risk and volatility, PRCT or AVNS? PROCEPT BioRobotics has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500. Comparatively, Avanos Medical has a beta of 1.15, indicating that its stock price is 15% more volatile than the S&P 500. Does the media favor PRCT or AVNS? In the previous week, PROCEPT BioRobotics had 6 more articles in the media than Avanos Medical. MarketBeat recorded 6 mentions for PROCEPT BioRobotics and 0 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.87 beat PROCEPT BioRobotics' score of 0.85 indicating that Avanos Medical is being referred to more favorably in the news media. Company Overall Sentiment PROCEPT BioRobotics Positive Avanos Medical Very Positive Do analysts rate PRCT or AVNS? PROCEPT BioRobotics presently has a consensus target price of $70.00, suggesting a potential upside of 112.12%. Given PROCEPT BioRobotics' stronger consensus rating and higher possible upside, equities analysts clearly believe PROCEPT BioRobotics is more favorable than Avanos Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PROCEPT BioRobotics 1 Sell rating(s) 2 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.60Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Do insiders & institutionals hold more shares of PRCT or AVNS? 89.5% of PROCEPT BioRobotics shares are held by institutional investors. Comparatively, 95.2% of Avanos Medical shares are held by institutional investors. 17.4% of PROCEPT BioRobotics shares are held by company insiders. Comparatively, 2.6% of Avanos Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryPROCEPT BioRobotics beats Avanos Medical on 9 of the 16 factors compared between the two stocks. Get Avanos Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AVNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVNS vs. The Competition Export to ExcelMetricAvanos MedicalMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$503.93M$6.89B$6.04B$21.68BDividend YieldN/A1.17%5.73%3.64%P/E Ratio-1.0826.2185.3129.62Price / Sales0.73191.04589.4495.25Price / Cash0.9021.8525.7317.79Price / Book0.605.1712.664.63Net Income-$392.10M$176.38M$3.31B$1.01B7 Day Performance-6.14%-1.46%-0.44%-1.84%1 Month Performance-11.20%6.91%8.70%0.55%1 Year Performance-51.88%24.74%76.70%13.43% Avanos Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVNSAvanos Medical1.9913 of 5 stars$10.86+1.5%N/A-52.5%$503.93M$692.50M-1.082,227Positive NewsPRCTPROCEPT BioRobotics2.9768 of 5 stars$35.24-2.0%$70.00+98.6%-54.1%$2.00B$224.50M-22.74430LMATLeMaitre Vascular3.9138 of 5 stars$87.49-0.4%$97.60+11.6%-5.0%$1.99B$219.86M42.47490AORTArtivion3.2425 of 5 stars$40.79-0.6%$43.13+5.7%+55.1%$1.94B$388.54M-97.121,600Analyst ForecastLQDALiquidia Technologies3.3573 of 5 stars$22.86+1.9%$32.38+41.6%+109.5%$1.93B$14M-13.4550ENOVEnovis3.6414 of 5 stars$31.30-2.2%$51.00+62.9%-26.2%$1.83B$2.11B-2.207,367News CoveragePositive NewsNVCRNovoCure4.1761 of 5 stars$14.50-1.1%$27.50+89.7%-14.3%$1.64B$605.22M-9.291,488CDRECadre2.5022 of 5 stars$37.54+2.4%$31.50-16.1%-4.6%$1.49B$567.56M39.932,284Analyst ForecastAnalyst RevisionCNMDCONMED4.5452 of 5 stars$46.42-3.6%$59.80+28.8%-33.5%$1.49B$1.31B13.153,900SSIISS Innovations InternationalN/A$6.80-5.4%N/AN/A$1.39B$20.65M0.004PLSEPulse Biosciences3.7466 of 5 stars$19.45+0.8%$22.00+13.1%+3.0%$1.30B$700K-18.52140 Related Companies and Tools Related Companies PROCEPT BioRobotics Competitors LeMaitre Vascular Competitors Artivion Competitors Liquidia Technologies Competitors Enovis Competitors NovoCure Competitors Cadre Competitors CONMED Competitors SS Innovations International Competitors Pulse Biosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:AVNS) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avanos Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avanos Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
